Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Home

Main sub menu

  • Investors
  • Careers
    • Working at Recipharm
    • The Recipharm story
    • Meet our employees
    • Current vacancies
  • Contact
    • Contact us
    • Development services contacts
    • Manufacturing services contacts
    • Locations
      • France
        • Fontaine
        • Kaysersberg
        • Monts
        • Pessac
      • Germany
        • Monheim
        • Wasserburg
        • Zwickau
      • India
        • Bengaluru
        • Karnal / Paonta Sahib
      • Israel
        • Ness Ziona
      • Italy
        • Brescia
        • Lainate
        • Masate
        • Paderno Dugnano
        • Pianezza
      • Portugal
        • Odivelas
        • Queluz
      • Spain
        • Parets
        • Leganés
      • Sweden
        • Höganäs
        • Stockholm city (HQ)
        • Karlskoga
        • Solna
        • Strängnäs
        • Uppsala
        • Uppsala Development
      • UK
        • Cramlington
        • Holmes Chapel
        • Queenborough
        • King’s Lynn
      • USA
        • Research Triangle Park

Main navigation

  • Development
    • Drug substance
    • Drug product
    • Analytical chemistry
    • Clinical trial material (CTM)
  • Manufacturing
    • Solids
    • Semi-solids
    • Liquids
    • Inhalation
    • Injectables
    • Ophthalmics
  • Solutions
    • Recipharm Analytical Solutions™
    • Recipharm Inhalation Solutions™
    • Recipharm Pathway to Clinic®
    • Serialisation
  • Bespak
  • Learn
  • Press & events
    • Press
    • Events
    • Reports
    • Insights
  • Our story
    • Recipharm in brief
    • Business model
    • Sustainability
    • Company history

Press & events

What's happening?

Stay updated on our latest news and events.

Press and Event

  • Press
  • Events
  • Reports
  • Insights
Displaying 1 - 10 of 406

Subscribe

Press

Recipharm names 2020 International Environmental Award winner

2021.03.02 Read more

Press

Delisting of shares from Nasdaq Stockholm

2021.02.19 Read more

Press

Notice of extraordinary general meeting in Recipharm AB (publ)

2021.02.16 Read more

Press

Recipharm applies for delisting of shares and summons to extraordinary general meeting

2021.02.15 Read more

Press

Recipharm bolsters biologics offering

2021.02.10 Read more

Press

Results of meeting of the holders of Recipharm convertible bonds: consent granted to correct error in terms and conditions

2021.02.03 Read more

Press

Recipharm and Medspray launch Resyca joint venture to exploit novel softmist technology for pharmaceutical applications

2021.02.01 Read more

Press

Statement by the Board of Directors of Recipharm regarding the public offer from Roar BidCo

2021.01.28 Read more

Press

Recipharm AB publishes report for the fourth quarter and full year 2020

2021.01.28 Read more

Press

Recipharm and binx health announce signing of a long-term supply agreement

2021.01.21 Read more

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Footer menu

  • Privacy policy
  • Cookies
  • Website terms
© 2021 Recipharm AB (publ). All rights reserved Stormfors Digitalbyrå